NIOX GROUP
 
Notifications
Clear all

NIOX - NIOX GROUP - Share Chat

Price: Market Cap.: (Ā£m)

NIOX Group plc is a UK-headquartered medical device company, globally recognised as a leader in respiratory diagnostics. It specialises in the non-invasive measurement of Fractional Exhaled Nitric Oxide (FeNO), a key biomarker for airway inflammation in asthma. The company’s core product portfolio, including the NIOX VEROĀ® and NIOX MINOĀ® devices, enables healthcare professionals to more accurately diagnose, monitor, and manage asthma by assessing steroid responsiveness. NIOX operates a business model combining device sales with recurring revenue from consumables. Its technology provides a rapid, point-of-care solution, aiding personalised asthma management and contributing to improved patient outcomes worldwide.

Posts: 1675
Topic starter
(@mrmultibagger)
Member
Joined: 3 years ago

Chat about NIOX GROUP


1 Reply
Posts: 1675
Topic starter
(@mrmultibagger)
Member
Joined: 3 years ago

NIOX GROUP: Is this a hidden gem or a value trap? Despite recent financial updates, the market seems undecided. With their focus on asthma diagnostics, do you see significant growth ahead, or are there underlying concerns? What's your strategy here?


Reply

Scroll to Top